Top Markets
Coin of the day
IDL Diagnostics AB (publ) IDL Diagnostics AB (publ)

IDL Diagnostics AB (publ)

IDLDX
Kedudukan dalam Saham #32452
Specializing in in vitro diagnostics (IVD), IDL Diagnostics AB (publ) develops... Specializing in in vitro diagnostics (IVD), IDL Diagnostics AB (publ) develops and markets diagnostic tests aimed at detecting cancer and bacterial infections within the Swedish market. Its product portfolio includes UBC Rapid, a point-of-care solution for both diagnosing and tracking bladder cancer; AroCell TK 210 ELISA, utilized as a biomarker for identifying tumor cells; and TUBEX TF, an in vitro diagnostic tool for pinpointing acute typhoid fever. Formerly operating as AroCell AB (publ), the company is scheduled to adopt the name IDL Diagnostics AB (publ) in May 2025. Established in 2000, its operations are headquartered in Stockholm, Sweden.
Harga Saham
$0.04367217
Disegerakkan terakhir: 2026-08-17
Modal Pasaran
$10.06M
Perubahan (1 hari)
3.99%
Perubahan (1 tahun)
-26.77%
Negara
SE
Perdagangan IDL Diagnostics AB (publ) (IDLDX)

Kategori

Sejarah pecahan saham untuk IDL Diagnostics AB (publ) (IDLDX)
Saham IDL Diagnostics AB (publ) (simbol: IDLDX) telah mengalami sejumlah 0 pecahan saham.
Pecahan saham terkini berlaku pada Aug 18, 2026.
Satu saham IDLDX yang dibeli sebelum Aug 18, 2026 kini bersamaan dengan 0 saham IDLDX.
Senarai pecahan saham
Tahun Pecahan Gandaan Gandaan Kumulatif
Tidak cukup data untuk tarikh yang disediakan.
Pecahan saham untuk syarikat pesaing atau serupa
Syarikat Bilangan pecahan saham Gandaan Kumulatif Negara
8 x34
US
7 x47
US
0 -
CN
0 -
US
4 x15
US